3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
-6.4227 0.2428 -0.0533 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8807 2.2844 0.4293 F 0 0 0 0 0 0 0 0 0 0 0 0
5.6588 0.3270 -0.2654 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.1556 -2.0188 0.4197 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6389 0.2128 -0.0586 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1185 -0.9466 0.1981 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1066 1.4094 -0.3080 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6383 -0.5563 0.0583 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2221 -0.8674 0.1716 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0895 0.7405 0.3037 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5454 -1.5547 -0.2969 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0563 0.2204 -0.0572 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4475 1.0391 0.1939 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9035 -1.2564 -0.4068 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3545 0.0406 -0.1613 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7696 -0.9176 0.1887 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7581 1.3661 -0.3019 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7140 0.2347 -0.0540 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2389 1.1124 -0.3092 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4329 1.5437 0.6241 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2139 -2.5704 -0.4967 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6100 -2.0331 -0.6841 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3459 -1.8884 0.3962 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2694 2.3127 -0.5060 H 0 0 0 0 0 0 0 0 0 0 0 0
1 18 1 0 0 0 0
2 13 1 0 0 0 0
3 15 1 0 0 0 0
4 9 2 0 0 0 0
5 9 1 0 0 0 0
5 12 1 0 0 0 0
5 19 1 0 0 0 0
6 16 2 0 0 0 0
6 18 1 0 0 0 0
7 17 1 0 0 0 0
7 18 2 0 0 0 0
8 9 1 0 0 0 0
8 10 2 0 0 0 0
8 11 1 0 0 0 0
10 13 1 0 0 0 0
10 20 1 0 0 0 0
11 14 2 0 0 0 0
11 21 1 0 0 0 0
12 16 1 0 0 0 0
12 17 2 0 0 0 0
13 15 2 0 0 0 0
14 15 1 0 0 0 0
14 22 1 0 0 0 0
16 23 1 0 0 0 0
17 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
N-(2-chloropyrimidin-5-yl)-3,4-difluorobenzamide
4.2 InChl
InChI=1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18)
4.3 InChlKey
IIBSHMFXVWTQSJ-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC(=C(C=C1C(=O)NC2=CN=C(N=C2)Cl)F)F
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病